首页> 中文期刊>世界病毒学杂志 >Reinfection risk of novel coronavirus(COVID-19):A systematic review of current evidence

Reinfection risk of novel coronavirus(COVID-19):A systematic review of current evidence

     

摘要

BACKGROUND There is recently a concern regarding the reinfection and reactivation of previously reCoVered coronavirus disease 2019(CoVID-19)patients.AIM To summarize the recent findings and reports of CoVID-19 reinfection in patients previously reCoVered from the disease.METHODS This study was a systematic review of current evidence conducted in August 2020.The authors studied the probable reinfection risk of novel coronavirus(CoVID-19).We performed a systematic search using the keywords in online databases.The investigation adheres to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses(PRISMA)checklist to ensure the reliability and validity of this study and results.RESULTS We reviewed 31 studies.Eight studies described reCoVered patients with reinfection.Only one study reported reinfected patients who died.In 26 studies,there was no information about the status of the patients.Several studies indicated that reinfection is not probable and that post-infection immunity is at least temporary and short.CONCLUSION Based on our review,we concluded that a positive polymerase chain reaction retest could be due to several reasons and should not always be considered as reinfection or reactivation of the disease.Most relevant studies in positive retest patients have shown relative and probably temporary immunity after the reCoVery of the disease.

著录项

  • 来源
    《世界病毒学杂志》|2020年第5期|79-90|共12页
  • 作者单位

    Iranian Research Center for HIV/AIDS,Iranian Institute for Reduction of High Risk Behaviors,Tehran University of Medical Sciences,Tehran 1586489615,Iran;

    HBOT Research Center,Golestan Hospital,Islamic Republic of Iran,Navy and AJA Medical University,Tehran 7134845794,Iran;

    School of Medicine,Iran University of Medical Sciences,Tehran 7134845794,Iran;

    Department of Radiology,School of Medicine,University of California,San Diego(UCSD),California,CA 587652458,United States;

    School of Medicine,Islamic Azad University,Tehran 7134845794,Iran;

    Department of Virology,School of Public Health,Tehran University of Medical Sciences,Tehran 7134845794,Iran;

    Department of Health Information Technology,Zabol University of Medical Sciences,Zabol 5486952364,Iran;

    Department of Health Information Technology,Khalkhal University of Medical Sciences,Khalkhal 1419733141,Iran;

    Department of Global Health and Socioepidemiology,Graduate School of Medicine,Kyoto University,Kyoto 215789652,Japan;

    Graduation Program of Health Sciences,Faculty of Medicine,Federal University of Mato Grosso,Cuiaba 458796523,Brazil;

    UniversitéAix-Marseille,Institutde Neuro-physiopathologie(INP),UMR 7051,Facultéde Pharmacie,27 Bd Jean Moulin,Marseille 546789235,France;

  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类 肿瘤学;
  • 关键词

    Reactivation; Reinfection; Postinfection; Coronavirus; CoVID-19; SARSCoV-2;

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号